La description :the leading site for news and procurement in the pharmaceutical industry...
Classement Alexa Global: # 320,692,Alexa Classement dans United States est # 158,231
Server:nginx...
L'adresse IP principale: 54.163.244.1,Votre serveur United States,Ashburn
ISP:Amazon Technologies Inc. TLD:com Code postal:us
Ce rapport est mis à jour en 02-Sep-2018
Created Date:
2000-06-20
Changed Date:
2017-10-12
Données techniques du pharmaceutical-technology.com
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations.
Notre service GeoIP a trouvé l'hôte pharmaceutical-technology.com.Actuellement, hébergé dans United States et son fournisseur de services est Amazon Technologies Inc. .
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé nginx contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
IP:54.163.244.1 ASN:14618 OWNER:AMAZON-AES - Amazon.com, Inc., US Country:US
HtmlToText
- the leading site for news and procurement in the pharmaceutical industry " / -- -- is using cookies we use them to give you the best experience. if you continue using our website, we'll assume that you are happy to receive all cookies on this website. continue learn more x x advertise with us search -- search log in log in register market & customer insight register advertise with us home about pharma technology focus magazine about us online advertise with us company a-z company releases contact us privacy policy terms and conditions clinical trials cold chain diseases drug development manufacturing market data technology analysis comment news events projects white papers videos home news advertise with us company a-z analysis about us products & services comment pharma technology focus magazine company releases research reports contact us projects events white papers videos deals clinical trials clinical trials projects analysis news suppliers white papers videos comment comment esc congress 2018: should cancer patients with af take doacs instead of warfarin? comment jama study puts fda’s breakthrough therapy label under the spotlight comment plaque psoriasis: strong phase iii results expected for ucb’s bimekizumab cold chain cold chain projects analysis news suppliers white papers videos comment comment roche’s rituxan biosimilar woes are just beginning comment blockbuster asthma drug xolair gains breakthrough status for food allergies comment viiv secures key phase iii win for once-monthly injectable hiv regimen diseases diseases projects analysis news suppliers white papers videos comment comment jama study puts fda’s breakthrough therapy label under the spotlight comment plaque psoriasis: strong phase iii results expected for ucb’s bimekizumab comment novo nordisk invests in glucose binding tech to stay ahead in diabetes market drug development drug development projects analysis news suppliers white papers videos comment comment jama study puts fda’s breakthrough therapy label under the spotlight comment plaque psoriasis: strong phase iii results expected for ucb’s bimekizumab comment novo nordisk invests in glucose binding tech to stay ahead in diabetes market manufacturing manufacturing projects analysis news suppliers white papers videos comment comment jama study puts fda’s breakthrough therapy label under the spotlight comment plaque psoriasis: strong phase iii results expected for ucb’s bimekizumab comment drug supply post-brexit may occur at the expense of pharma r&d market data market data projects analysis news suppliers white papers videos comment comment jama study puts fda’s breakthrough therapy label under the spotlight comment plaque psoriasis: strong phase iii results expected for ucb’s bimekizumab comment drug supply post-brexit may occur at the expense of pharma r&d obsessions obsessions digital disruption deals digital disruption at&t and softbox use drones to transport medicines to disaster zones data protection “it should not be used by businesses”: wire ceo on whatsapp update digital disruption what half a century of innovation tells us about the tech industry all all sections home news advertise with us company a-z analysis about us products & services comment pharma technology focus magazine company releases research reports contact us projects events white papers videos deals trending: clinical trials cold chain diseases manufacturing drug supply post-brexit may occur at the expense of pharma r&d by globaldata healthcare with less than a year left for the uk to leave the eu, ensuring an undisrupted flow of medicines in... regulation campaigners warn stockpiling medicines for a no-deal brexit could cost £2bn technology at&t and softbox use drones to transport medicines to disaster zones philanthropy in pharma: a look inside the ispe foundation regulation abortion in england: legalising home medical abortion pills regulation brexit and the pharmaceutical industry: what happens if there’s no deal? drug development a research headache: improving the understanding of chronic migraine latest news news -- multiple sclerosis drug slows brain shrinkage in nih-funded trial 31 august 2018 -- news -- deals and m&as this week: bluebird bio, tjoapack, emergent biosolutions 31 august 2018 -- news -- vertex and genomics partner to use human genetics for precision medicines 31 august 2018 -- load more news -- get important industry news and analysis sent to your inbox – sign up to our e-newsletter here comment expert commentary & analysis from globaldata 31 aug comment esc congress 2018: should cancer patients with af take doacs instead of warfarin? 31 aug comment jama study puts fda’s breakthrough therapy label under the spotlight 31 aug comment plaque psoriasis: strong phase iii results expected for ucb’s bimekizumab 31 aug comment novo nordisk invests in glucose binding tech to stay ahead in diabetes market view all comment most read deals and m&as this week: bluebird bio, tjoapack, emergent biosolutions at&t and softbox use drones to transport medicines to disaster zones philanthropy in pharma: a look inside the ispe foundation abortion in england: legalising home medical abortion pills brexit and the pharmaceutical industry: what happens if there’s no deal? company releases press release munit sponsor 8th american ddf munit and its affiliates jetpharma and microchem are delighted to be a sponsor at the 8th american ddf summit in... munit, jetpharma, microchem malvern panalytical announces webinars throughout september press release nsf releases two new pharma elearning sessions nsf international provides a comprehensive range of support services for the pharmaceutical industry covering consulting, training, auditing, remediation, quality systems... nsf international, pharma biotech innovative pharmaceutical and biopharmaceutical primary packaging press release the consequences of a no-deal brexit the uk brexit secretary dominic raab has announced that even though the uk government is... company whitepapers major regulatory change for combination products in the eu anteris medical growth forecast for emerging pharma markets pharmaconsult global the future of the pharmaceutical industry nsf international, pharma biotech regulatory consulting and labelling translation services corex regulatory consulting gmbh weibel cds: safer, easier, and faster drug delivery weibel cds innovations in api solubility and bioavailability laboratoria smeets getting to the bottom of data integrity: four to explore nsf international, pharma biotech company a-z more röchling medical manufacturing and r&d; services for pharmaceutical packaging qualimetrix analytical and lifecycle development services for pharmaceuticals innovasystems automated test solutions for pharmaceutical drug delivery systems zenith technologies delivering pharmaceutical manufacturing execution systems (mes), automation, and process control ge healthcare life sciences bioprocessing solutions for development and manufacture of biotherapeutics and vaccines sirion biotech customised viral vectors for cell modelling, gene therapy, and vaccination research and development pbsc clean room doors, emergency escape panels, vision panels, hygienic lift trolleys, air and water showers evolve equipment, maintenance, and design services for pharmaceutical laboratories fps food and pharma systems size-reduction machines and containment solutions for api starodub regulatory affairs and operations for drugs and medical devices plastiape group medical devices and packaging solutions for the pharmaceutical industry beate beime pharma consulting readability tests for pharmaceutical and medical device applications regmed prof clinical services and regulatory consultation for the eaeu quality assurance management (qam) inspection and analytical services for the pharmaceutical industry corex regulatory consulting gmbh regulatory labelling and consultin
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR LCN.COM Ltd.
SERVERS
SERVER com.whois-servers.net
ARGS domain =pharmaceutical-technology.com
PORT 43
TYPE domain RegrInfo DOMAIN
NAME pharmaceutical-technology.com
CHANGED 2017-10-12
CREATED 2000-06-20
STATUS clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited clientTransferProhibited https://icann.org/epp#clientTransferProhibited clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Nous utilisons des cookies pour personnaliser votre expérience sur notre site. En poursuivant votre navigation, vous acceptez cette utilisation. Apprendre encore plus
pharmaceutical-technology.com rapport :
Visitez le site